Advanced Enzyme Technologies Ltd
Advanced Enzyme Buys Back 26,426 Shares for Rs. 70.37 Lakh on Oct 16
BUYBACK
▲ Positive Development
LOW RISK
📅 Filed on BSE: 16 Oct 2026, 05:41 PM IST · BSE ID: aa4f3046-1271-4a0c-92dc-c9caa6ccdf75
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought back some of its own shares from the stock market on October 16, 2026.
🤖 AI Summary
- Advanced Enzyme Technologies bought 26,426 shares on October 16, 2026.
- Total expenditure for the day's buyback was Rs. 70,37,282.35.
- The average acquisition price per share was ₹266.2855.
- Cumulative shares bought back reached 20,29,733 as of October 16, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares bought on October 16, 2026
26,426
Total Expenditure on October 16, 2026
Rs. 70,37,282.35
Average Price of Acquisition
₹266.2855
Cumulative Equity Shares bought back as on October 16, 2026
20,29,733
🏢 How This Affects the Company
The buyback reduces outstanding share count, potentially increasing earnings per share for remaining shareholders. This expenditure impacts the company's cash reserves.
Continued buyback activity indicates management confidence in the company's valuation but also signals deployment of cash that could be used for other strategic initiatives.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. The buyback is being conducted from the open market.
👤
Who Is Affected
All shareholders are indirectly affected as the buyback reduces the total number of outstanding shares.
🔍
Management Signal
This ongoing buyback signals management's belief that the company's shares are undervalued at current market prices.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Daily buyback reports for further share accumulation.
Next quarterly results for overall financial performance review.
Completion status of the entire buyback program.
LOW RISK
Buyback is a standard corporate action; risks are primarily related to cash availability and market price movement.
💡 Investor Takeaway
Advanced Enzyme Technologies bought 26,426 shares for Rs. 70,37,282.35 on October 16, 2026, at an average price of ₹266.2855. Cumulative buyback stands at 20,29,733 shares.
⚖️ Strengths & Concerns
✅ Positives
- Company actively executing its share buyback program, demonstrating capital allocation strategy.
- Consistent buyback activity signals management's assessment of undervaluation and commitment to shareholder value.
⚠️ Concerns
- Significant portion of the buyback program has been completed, reducing available cash.
- No new operational or business growth updates accompanying the buyback disclosure.
📅 Company Track Record
Previous buyback activity shows Advanced Enzyme Technologies purchased 46,178 shares on Oct 13, 2026, and 26,000 shares on Oct 12, 2026, indicating consistent buyback execution.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
How many shares did Advanced Enzyme Technologies buy back on October 16, 2026?
Advanced Enzyme Technologies bought back 26,426 Equity Shares on October 16, 2026.
What was the total expenditure for Advanced Enzyme's share buyback on October 16, 2026?
The total expenditure for the buyback on October 16, 2026, was Rs. 70,37,282.35.
What is the average acquisition price of shares bought back by Advanced Enzyme on October 16, 2026?
The average price of acquisition for shares bought back on October 16, 2026, was ₹266.2855.
Questions based on this BSE filing only. For information purposes.